Umoja Biopharma
Signal active
Organization
Contact Information
Overview
Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer. The company's treatment approach retools a patient’s immune system in vivo to direct potent anti-cancer immune cells to a patient’s tumor, augmenting the body’s natural mechanisms for fighting cancer.
About
Industries
Information Technology, Biotechnology, Biopharma, Developer Platform
Founded
2019
Employees
101-250
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Umoja Biopharma headquartered in United States, North America, operates in the Information Technology, Biotechnology, Biopharma, Developer Platform sector. The company focuses on Information Technology and has secured $12.6B in funding across 48 round(s). With a team of 101-250 employees, Umoja Biopharma is actively contributing to advancements in Information Technology. Their latest funding round, Series B - Umoja Biopharma, raised $210.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
7
Lead Investors
0
Total Funding Amount
$263.0M
Details
3
Umoja Biopharma has raised a total of $263.0M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2020 | Early Stage Venture | 53.0M | ||
| 2019 | Seed | |||
| 2021 | Early Stage Venture | 210.0M |
Investors
Umoja Biopharma is funded by 19 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| RTW Investments | - | FUNDING ROUND - RTW Investments | 210.0M |
| Umoja Biopharma | - | FUNDING ROUND - Umoja Biopharma | 210.0M |
| SVB Securities | - | FUNDING ROUND - SVB Securities | 210.0M |
| Umoja Biopharma | - | FUNDING ROUND - Umoja Biopharma | 210.0M |
Recent Activity
There is no recent news or activity for this profile.